𝔖 Bobbio Scriptorium
✦   LIBER   ✦

61 Tiotropium Respimat in cystic fibrosis: Efficacy and safety results of phase III randomized placebo-controlled trial

✍ Scribed by Ratjen, F.; Koker, P.; Geller, D.; Langellier-Cocteaux, B.; Maulf, F. Le; Kattenbeck, S.; Moroni-Zentgraf, P.; Elborn, J.S.

Book ID
122072082
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
68 KB
Volume
12
Category
Article
ISSN
1569-1993

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy and safety of golimumab in pati
Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial
✍ Robert D. Inman; John C. Davis Jr.; DΓ©sirΓ©e Van Der Heijde; Laura Diekman; Joach πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 168 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO‐RAISE study. ## Methods Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score β‰₯4, and a back pain score of β‰₯4 were randomly assigned in a 1.8:1.8:1